Article
Hyperlipidemia and Statin Use after Allogeneic Hematopoietic Stem Cell Transplantation
23 Aug 2011
Abstract excerpt
An increased incidence of cardiovascular complications has been documented in recipients of allogeneic hematopoietic stem cell transplantation (HSCT). Despite this, little is known about the risk factors for hyperlipidemia or the role of lipid-lowering therapy early after transplantation. We performed a retrospective analysis of all patients who underwent allogeneic HSCT at the Dana-Farber Cancer Institute from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
